Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

Keywords

Metformin, Overweight, Medicine, Type 2 diabetes, Diabetes mellitus

References

• United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy1998
• United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes MellitusRobert G. Turner, Carole Cull, Rury Holman — 1996
• Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDinesh Nagi, John Yudkin — 1993
• Biguanides and NIDDMClifford J. Bailey — 1992
• Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.Kenneth Cusi, Agostino Consoli, Ralph A. DeFronzo — 1996
• Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.John J. Nolan, Bernhard Ludvik, P. Beerdsen — 1994
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Uk-Prospective-Diabetes-Study-Group — 1998
• UK Prospective Diabetes Study (UKPDS) XI: Biochemical Risk Factors in Type 2 Diabetic Patients at Diagnosis Compared with Age‐matched Normal SubjectsSusan E. Manley, Laurent Meyer, Neil Haw. — 1994
• U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive DiseaseU.K. Prospective Diabetes Study Group — 1995
• UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 DiabetesU.K. Prospective Diabetes Study Group — 1998
• MetforminClifford J. Bailey, Robert C. Turner — 1996

Cited by

• Hypoglykämie und Herzrhythmusstörungen bei Patienten mit Diabetes Typ 2M Hanefeld, Xenia Ganz, Christa Nolte — 2014
• Factors Associated With Poor Glycemic Control or Wide Glycemic Variability Among Diabetes Patients in Hawaii, 2006–2009Deborah Taira Juarez, Tetine Sentell, Sheri Tokumaru — 2012
• Digestive hemorrhage caused by a Meckel's diverticulum in a metformin‐treated patient: is there any connection?M.A. Burrull‐madero, A. Del‐villar‐ruiz, Santiago Grau-Cerrato — 2001
• Die Insulinresistenz beim polyzystischen Ovar-SyndromAnnika K. Schröder, S. Tauchert, Olaf Ortmann — 2003
• The plasma glucose level--a continuous risk factor for vascular disease in both diabetic and non-diabetic people.Hertzel C. Gerstein — 2001
• Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideasKristina Fjelkestam — 1999
• Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 DiabetesChen‐Pin Wang, Carlos Lorenzo, Sara Espinoza — 2014
• Insulin therapy in the elderly: becoming the normGM Peterson — 2009
• The effect of acute hyperglycaemia on brachial artery flow mediated dilatation in normal volunteers.Jean‐Louis Rocca — 2000
• Risks of coronary heart disease in women: current understanding and evolving concepts.Klaus Meier — 2000
• Impact of Standalone Personal Health Record Use on Clinical Outcomes of Patients with Type 2 Diabetes: An Intervention Mixed Methods StudyKevin T. Fuji — 2013
• Psychological issues and treatments for people with diabetes.Isidro Martí — 2001
• Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.Dmitry Rozhdestvenskiy — 2001
• Diabetes Screening in Canada (DIASCAN) Study: prevalence of undiagnosed diabetes and glucose intolerance in family physician offices.V. L. Castellazzi — 2001
• Effects of improved glycaemic control on endothelial function in patients with type 2 diabetesWarwick Bagg, Gillian Whalley, Greg Gamble — 2001
• Postoperative management of the diabetic patient.勝俊 瀧 — 2001
• Diabetes im AlterA Meyer — 2009
• Porphyromonas gingivalis infection is associated with elevated C-reactive protein in nonobese Japanese type 2 diabetic subjects.卓之 星野, 哲郎 及川, 裕司 蒲生 — 2002
• Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.光男 望月 — 2002
• Drugs for cardiovascular risk reduction in the diabetic patientBiblioteca Universitaria. Unidad de Gestión de Publicaciones Periódicas — 2001

Related papers

• Metformin for Prevention of Type 2 DiabetesAleda M. Hess, Donald L. Sullivan — 2004
• A study on prevalence of overweight and obesity amongst school children of BangaloreSunil Kumar D. A., M. Rohith, Greeva Philip — 2018
• The Study on Overweight and Obesity among Primary School Pupils in Kaifu District in ChangshaMo Juan, Chao Huang — 2008
• Differences in the prevalence of diagnosis of overweight-obesity in Spanish children according to the diagnostic criteria set used.María Julia Ajejas Bazán, Isabel Jiménez‐Trujillo, Julia Wärnberǵ — 2017
• Cardiovascular risk factors attributable to obesity and overweight in Switzerland.C. Davin, Péter Vollenweider, Gérard Waeber — 2012
• Evaluation of the metformin initiation rate in veterans with newly identified type 2 diabetes.Kelsey J. Zenti, Meaghan Meyer, Nancee V. Waterbury — 2021
• Analysis on overweight and obesity of adults in Shanxi ProviceLing Liu — 2007
• PREVALENCE OF OVERWEIGHT, OBESITY AND RELATED FACTORS AMONG WOMEN AGED 40-59 IN CANG LONG DISTRICT, TRA VINH PROVINCE IN 2017Truc Le Thanh Nguyen, Nhi Thi Thuy Ngo, Linh Hoang Nguyen — 2018
• A comparative study of prevalence of overweight and obesity in children in different provinces of Saudi Arabia.M.A.F. El‐Hazmi — 2002
• The Utility of Body Mass Index as Measure of Overweight and Obesity among Adults in Republic of Macedonia Screening StudyMaja Jordanova, Katerina Rebok, Lozenka Ivanova — 2016